KRAS protein expression becomes progressively restricted during embryogenesis and in adulthood

Area of Science:

• Molecular Biology
• Developmental Biology
• Cancer Biology

Background:

• KRAS mutations are prevalent in human cancers.
• Wild-type KRAS is crucial for embryonic development.
• Normal KRAS protein expression patterns remain largely uncharacterized at the tissue level due to antibody limitations.

Purpose of the Study:

• To investigate the normal expression patterns of KRAS protein during embryonic development and in adult tissues.
• To identify specific cell types and subcellular localizations of KRAS protein.
• To provide a foundation for understanding KRAS-driven oncogenesis.

Main Methods:

• Utilized the citrine-Kras mouse model, where Citrine-KRAS fusion protein serves as a surrogate for endogenous KRAS.
• Employed immunolabeling with a GFP antibody to detect Citrine-KRAS on tissue sections.
• Analyzed KRAS protein expression dynamics during embryonic development, near birth, and in adult tissues.

Main Results:

• Detected KRAS protein expression across a broad spectrum of embryonic organs and tissues.
• Observed a decrease in KRAS expression near birth, particularly in mesenchymal cells.
• Found that KRAS expression becomes restricted to specific cell types in adults, with varying subcellular localization (cell membrane and cytoplasm) across different cell types.

Conclusions:

• Revealed previously unknown developmental, tissular, cell-specific, and subcellular expression dynamics of KRAS protein.
• The findings offer critical insights into why certain cell types are susceptible to KRAS mutations during cancer initiation.
• Establishes a valuable resource for future research on KRAS function and its role in cancer.